Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-24

Clinical Trial Update: Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment

View source ↗

Summary

A completed clinical trial identifying genetic predictors of severe acne vulgaris and evaluating the outcome of oral isotretinoin treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Duke University | Conditions: Acne Vulgaris, Isotretinoin | Status: COMPLETED